Spore.Bio Revolutionizes Microbiological Testing with AI-Powered, 10-Minute Sample Analysis
October 3, 2026
Spore.Bio fuses biology, imaging, and artificial intelligence to analyze samples in about 10 minutes with the Louis connected device, slashing the time from days required by conventional culture tests.
Louis uses multi‑source lighting and AI to detect, count, and identify bacteria, yeasts, and moulds, removing traditional culture steps and chemical staining from the workflow.
The company offers a digital platform that centralizes data for real‑time monitoring across multiple production sites, enabling rapid detection of irregularities and strengthening reactive quality control.
Spore.Bio reframes microbiological surveillance as a proactive, automated quality‑management system rather than a delayed, reactive process.
Amine Raji co‑founded Spore.Bio in 2023 with Maxime Mistretta and Mohamed Tazi to modernize microbiological monitoring across food, pharmaceutical, cosmetics, and environmental services.
Raji brings industrial experience from Nestlé (2017–2022) in maintenance and project engineering, informing his approach to production challenges and performance.
Beyond Spore.Bio, Raji is a partner at No Label Ventures, investing in early‑stage deeptech and AI startups, including Uncovr and Davis AI.
Summary based on 1 source
Get a daily email with more AI stories
Source

We are Tech • Oct 3, 2026
Amine Raji Bets on AI Imaging to Transform Quality Control in Global Industries